UnknownNot Applicable

Dengue Serostatus Study in the Philippines

2,996 participantsStarted 2016-11

Plain-language summary

This is an observational study for 5 years, and aims to determine the risk of developing dengue among Philippine children who are eligible to receive the dengue vaccine during the DOH mass dengue vaccination, by dengue serostatus at baseline.

Who can participate

Age range9 Years – 14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Provide signed informed consent and assent (as applicable) * Be a child belonging to the specified age group and resident of the targeted communities of the DOH dengue mass immunization * Be eligible to receive dengue vaccine during the DOH dengue mass immunization in 2017 Exclusion criteria: * Any subject whose parent/guardian refuse to provide informed consent and/or assent * Children who do not belong to the specified age groups and not residents of the targeted communities * Children \<9 years old * Children with history of bleeding disorder * Any subject previously enrolled in a dengue vaccine clinical trial

What they're measuring

virologically-confirmed dengue (VCD)

Timeframe: 5 years

Trial details

NCT IDNCT03465254

SponsorUniversity of the Philippines

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10-31

View on ClinicalTrials.gov More Dengue trials